Nearly 25% of patients with chronic coronary heart disease have died or are re-hospitalized within six months of first hospitalization. The fault is the lack of monitoring of prescribed treatments and risky behavior.
Six months after their first hospitalization, nearly a quarter of patients with chronic coronary artery disease ("chronic ischemic heart disease") died or were rehospitalized. This result, derived from a study by the European Society of Cardiology, could however be avoided because it is linked to poor monitoring of treatment.
Coronary insufficiency that leads to heart failure
Ischemic heart disease is a cardiac involvement of partially clogged coronary arteries that no longer provides enough oxygenated blood to the heart muscle. It is manifested by coronary and cardiac insufficiency.
The study is based on follow-up data from 2 203 patients from 10 European countries with both types of deficiencies.
Six months after their first hospital appointment for this condition, 522 people died or were rehospitalized. And this, mainly because of a cardiovascular problem. These patients were generally elderly and had a history of peripheral revascularization, chronic renal failure or chronic obstructive pulmonary disease.
Nearly 35,000 dead in France
"We have identity of clinical factors related to these risks of death and re-hospitalization," says Michel Komajda, cardiologist at the Pitié-Salpétrière in Paris and professor at the Pierre and Marie Curie University. After the first appointment at the hospital, the patients have a prescription and take the recommended medication. Six months later, on the other hand, the prescription rate of these treatments decreases: the patients are treated less than at the beginning and increase the risk of complications.
"It is possible that we do not send enough patients to a cardiologist or a general practitioner and their prescriptions are not renewed," says Michel Komajda.
Lack of medical follow-up, refusal or impossibility of taking treatment by the patients ... The reasons for the decrease of the follow-up of the prescriptions can be multiple but, the consequences remain the same.
In France, 34,870 people died of ischemic heart disease in 2011.